HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Schröder, C. H. Articles by Kaerner, H. C. Search for Related Content PubMed PubMed Citation Articles by Schröder, C. H. Articles by Kaerner, H. C. Agricola Articles by Schröder, C. H. Articles by Kaerner, H. C.

Neuropathogenicity of Herpes Simplex Virus in Mice: Protection against Lethal Encephalitis by Co-infection with a Non-encephalitogenic Strain

Institute for Virus Research, German Cancer Research Center, Heidelberg, Federal Republic of Germany
and¹ Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, U.S.A.

Intraperitoneal infection of susceptible mice with an apathogenic herpes simplex virus type 1 (HSV-1) strain prevented the lethal outcome of a challenge infection with a pathogenic strain, even if the challenge preceded the protective infection. It was found that the protective inoculation blocks the initial replication of the challenge virus. In addition, intraperitoneal infection with the protective HSV-1 strain led to the induction of a refractory state in the central nervous system, resulting in resistance to direct intracranial infection with HSV-1. This state is also inducible locally by intracerebral inoculation of a non-replicating mutant virus. The results indicate that HSV-1 strains differing in neurovirulence may differ in the induction or the sensitivity to this protective effect. Experiments with non-replicating HSV-1 temperaturesensitive strains demonstrated that protection against lethal infection does not depend on replication or expression of late genes of the protective strain. Inoculation of animals with detergent-soluble extracts of infected cells or infected and u.v.-irradiated syngeneic cells protected the animals against co-infection with encephalitogenic challenge virus. The experiments define this protective effect as an antigen-induced immediate host defence mechanism active within 24 h post-infection.

Keywords: HSV-1, neuropathogenicity, protection, host defence

^* Mailing address: Institut füt Virusforschung, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 6900 Heidelberg 1, F.R.G.

Received 31 March 1982; accepted 31 May 1983.